Neuroscientists have discovered how the brain distinguishes between visual motion occurring in the external world from that caused by the observer moving through it. Known as the 'motion-source ...
More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...
The potential for cognitive motor dissociation in patients who are behaviourally unresponsive after a severe brain injury ...